Related Experiment Video
Updated: Aug 20, 2026
Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
Rapid method for beta2-transferrin in cerebrospinal fluid leakage using an automated immunofixation electrophoresis
Christine Papadea1, Rodney J Schlosser
1Division of Laboratory Medicine, Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston 29425, USA. papadecn@musc.edu
Insights
A new rapid method accurately detects beta(2)-transferrin (beta-2 trf), a key marker for cerebrospinal fluid (CSF) leakage, using unconcentrated samples. This advancement aids faster diagnosis of CSF leaks.
Area of Science:
- Biochemistry
- Clinical Diagnostics
- Analytical Chemistry
Background:
- Beta(2)-transferrin (beta-2 trf) is a specific biomarker for cerebrospinal fluid (CSF) leakage, detectable in various bodily fluids.
- Traditional immunofixation electrophoresis (IFE) for beta-2 trf detection is time-consuming and requires large sample volumes.
Observation:
- A novel, rapid method utilizing high-resolution agarose gels and an automated electrophoresis system was developed for beta-2 trf detection.
- The method employs unconcentrated samples with multiple applications on the gel, optimizing sensitivity.
Findings:
- The developed 2.5-hour procedure demonstrated high reproducibility (CV <2.5%) and a low limit of detection (0.002 g/L) for beta-2 trf.
- Results from clinical samples showed excellent concordance with a reference laboratory, validating the method's accuracy.
- The test's utilization increased significantly after implementation, indicating clinical utility.
Implications:
- This rapid and reliable method facilitates prompt diagnosis of suspected CSF leakage in clinical settings.
- The enhanced sensitivity and reduced sample volume requirements improve diagnostic efficiency and patient care.
- The method offers a valuable alternative to existing, more cumbersome techniques for beta-2 trf analysis.
Background:
Beta(2)-transferrin (beta-2 trf) is a desialated isoform of transferrin found only in cerebrospinal fluid (CSF), ocular fluids, and perilymph. In aural, nasal, and wound drainages, this protein is an important marker of CSF leakage. Immunofixation electrophoresis (IFE) on agarose gels is a widely accepted qualitative technique for detection of small amounts of beta-2 trf, but disadvantages include lengthy transfer immunoblotting techniques or the requirement of at least 2 mL of sample.
Methods:
Using eight applications of unconcentrated sample on high-resolution agarose gels with an automated electrophoresis system (Helena SPIFE 3000), we developed a rapid method for beta-2 trf. Evaluation studies included reproducibility of migration distance (mm), limit of detection, specificity, and concordance of results compared with those reported by a reference laboratory. Neuraminidase-treated serum was the source of beta-2 trf for our sensitivity and specificity studies. Transferrin was measured by rate nephelometry.
Results:
The 2.5-h procedure demonstrated reproducible migration (CV <2.5%) on five lots of gels. Detection of beta-2 trf at 0.002 g/L in an unconcentrated sample was attributed to reproducible application, quality of the anti-trf antiserum, and a sensitive acid violet stain. Our beta-2 trf findings (two negative and five positive) in seven available clinical samples agreed with the reference laboratory results. In 12 months after its inception, this test was ordered 48 times vs 13 in the previous year when testing was sent out.
Conclusion:
This method provides physicians with a rapid, reliable aid in the diagnosis of suspected CSF leakage, as described in a case report.
More Related Videos
11:13In Vitro Permeation of FITC-loaded Ferritins Across a Rat Blood-brain Barrier: a Model to Study the Delivery of Nanoformulated Molecules
Published on: August 22, 2016
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020